Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients

Clinical trial NCT01125189 · COMPLETED

Trial details

NCT number: NCT01125189
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C Virus

Start date: 2010-07-01
Primary completion: 2012-04-01
Enrollment: 558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.